Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02273453Phase 1Completed
Phase 1, randomised, double-blind trial of Songha Night in Insomnia (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Pupillary Unrest Index at Day 7. Started Feb 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02273453.